100019-9 |
ALK gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100019-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
ALK gene Mut Anl Bld/T |
|
|
|
N |
|
ALK receptor tyrosine kinase; Anaplastic lymphoma kinase (Ki-1); Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NBLST3; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10002-4 |
R wave duration.lead II |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
R wave duration in lead II |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10002-4 |
|
EKG |
|
|
Observation |
|
|
|
0 |
R wave dur L-II |
|
|
|
Y |
|
2; Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave dur L-II; R wave dur L-II; Random; Right |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
100020-7 |
GNA11 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100020-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
GNA11 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; FBH; FBH2; FHH2; G protein subunit alpha 11; GNA-11; HHC2; HYPOC2; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100021-5 |
GNAQ gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100021-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
GNAQ gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; CMC1; G protein subunit alpha q; G-ALPHA-q; GAQ; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; SWS; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100022-3 |
IDH1 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100022-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
IDH1 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; HEL-216; HEL-S-26; IDCD; Identity or presence; IDPC; isocitrate dehydrogenase (NADP(+)) 1, cytosolic; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; PICD; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100023-1 |
IDH2 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100023-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
IDH2 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; D2HGA2; ICD-M; Identity or presence; IDH; IDHM; IDP; IDPM; isocitrate dehydrogenase (NADP(+)) 2, mitochondrial; mNADP-IDH; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100024-9 |
SETBP1 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100024-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
SETBP1 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRD29; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; SET binding protein 1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100025-6 |
SRSF2 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100025-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
SRSF2 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; PR264; Random; SC35; SC-35; serine and arginine rich splicing factor 2; SFRS2; SFRS2A; SRp30b; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100026-4 |
MET gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100026-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
MET gene Mut Anl Bld/T |
|
|
|
N |
|
AUTS9; Blood; DFNB97; HGFR; Identity or presence; MET proto-oncogene, receptor tyrosine kinase; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; RCCP2; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100027-2 |
SMAD4 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100027-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
SMAD4 gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100028-0 |
FBXW7 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100028-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
FBXW7 gene Mut Anl Bld/T |
|
|
|
N |
|
AGO; Blood; CDC4; F-box and WD repeat domain containing 7; FBW6; FBW7; FBX30; FBXO30; FBXW6; hAgo; hCdc4; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; SEL10; SEL-10; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100029-8 |
Cancer related multigene analysis |
Find |
Plas.cfDNA |
Pt |
Doc |
Molgen |
|
ACTIVE |
Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
100029-8 |
|
Molgen |
|
|
Both |
|
|
|
0 |
Cancer multigene analysis Plas.cfDNA |
|
|
|
N |
|
Cancer multigene analysis; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Pl; Plasma; Plsm; Point in time; Random |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10003-2 |
R wave duration.lead III |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
R wave duration in lead III |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10003-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
R wave dur L-III |
|
|
|
Y |
|
3; Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave dur L-III; R wave dur L-III; Random; Right |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
100030-6 |
Axis I: Temporal aspects score |
Score |
^Patient |
Pt |
Qn |
Mainz Pain Staging System |
|
ACTIVE |
Axis I: Temporal aspects score [Mainz Pain Staging System] |
|
ADD |
DefinitionDescription |
|
|
score |
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
|
|
SURVEY.PAIN |
|
100030-6 |
|
Mainz Pain Staging System |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey |
2.72 |
2.72 |
|
|
|
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
{score} |
|
|
|
0 |
100031-4 |
Axis II: Spatial aspects score |
Score |
^Patient |
Pt |
Qn |
Mainz Pain Staging System |
|
ACTIVE |
Axis II: Spatial aspects score [Mainz Pain Staging System] |
|
ADD |
DefinitionDescription |
|
|
score |
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
|
|
SURVEY.PAIN |
|
100031-4 |
|
Mainz Pain Staging System |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
2; MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey |
2.72 |
2.72 |
|
|
|
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
{score} |
|
|
|
0 |
100032-2 |
Axis III: Drug taking behavior score |
Score |
^Patient |
Pt |
Qn |
Mainz Pain Staging System |
|
ACTIVE |
Axis III: Drug taking behavior score [Mainz Pain Staging System] |
|
ADD |
DefinitionDescription |
|
|
score |
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
|
|
SURVEY.PAIN |
|
100032-2 |
|
Mainz Pain Staging System |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
3; Drugs; MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey |
2.72 |
2.72 |
|
|
|
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
{score} |
|
|
|
0 |
100033-0 |
Axis IV: Utilization of the health care system score |
Score |
^Patient |
Pt |
Qn |
Mainz Pain Staging System |
|
ACTIVE |
Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |
|
ADD |
DefinitionDescription |
|
|
score |
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
|
|
SURVEY.PAIN |
|
100033-0 |
|
Mainz Pain Staging System |
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Axis IV: Use of the health care system score; MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey |
2.72 |
2.72 |
|
|
|
|
�© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission. |
|
|
{score} |
|
|
|
0 |
100034-8 |
Provider of automated external defibrillator use |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Provider of automated external defibrillator use |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
100034-8 |
|
|
|
|
Observation |
|
|
|
0 |
Provider of AED |
|
|
|
N |
|
Auto; Automated detection; Elec; Elect; Electr; EXT; Nominal; Point in time; Random; TRAUMA; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100035-5 |
Exam finding location |
Find |
Chest |
Pt |
Nom |
|
|
ACTIVE |
Exam finding location of Chest |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
100035-5 |
|
|
|
|
Observation |
|
|
|
0 |
Exam finding location Chest |
|
|
|
N |
|
Finding; Findings; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Thorax |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100036-3 |
Exam finding location |
Find |
Lung |
Pt |
Nom |
|
|
ACTIVE |
Exam finding location of Lung |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
100036-3 |
|
|
|
|
Observation |
|
|
|
0 |
Exam finding location Lung |
|
|
|
N |
|
Finding; Findings; H+P; H+P.PX; Nominal; P prime; Point in time; Pulmonary; Random |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100037-1 |
Patient contact disposition |
Type |
EMS unit |
Pt |
Nom |
|
|
ACTIVE |
Patient contact disposition EMS unit |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
100037-1 |
|
|
|
|
Observation |
|
|
|
0 |
Patient contact disposition EMS unit |
|
|
|
N |
|
Emergency Medical Service(s); Nominal; Point in time; Random; TRAUMA; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100038-9 |
Patient evaluation disposition |
Type |
EMS unit |
Pt |
Nom |
|
|
ACTIVE |
Patient evaluation disposition EMS unit |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
100038-9 |
|
|
|
|
Observation |
|
|
|
0 |
Patient eval disposition EMS unit |
|
|
|
N |
|
Assessment; Emergency Medical Service(s); Eval; H&P; History and physical; Nominal; Patient eval disposition; Point in time; Random; TRAUMA; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100039-7 |
Crew disposition for patient care |
Type |
EMS unit |
Pt |
Nom |
|
|
ACTIVE |
Crew disposition for patient care EMS unit |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
100039-7 |
|
|
|
|
Observation |
|
|
|
0 |
Crew disposition EMS unit |
|
|
|
N |
|
Emergency Medical Service(s); Nominal; Point in time; Random; TRAUMA; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10004-0 |
R wave duration.lead V1 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
R wave duration in lead V1 |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10004-0 |
|
EKG |
|
|
Observation |
|
|
|
0 |
R wave dur L-V1 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave dur L-V1; R wave dur L-V1; Random; Right |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
100040-5 |
Patient transport disposition |
Type |
EMS unit |
Pt |
Nom |
|
|
ACTIVE |
Patient transport disposition EMS unit |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
100040-5 |
|
|
|
|
Observation |
|
|
|
0 |
Pt transport disposition EMS unit |
|
|
|
N |
|
Emergency Medical Service(s); Nominal; Point in time; Pt transport disposition; Random; TRAUMA; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |